Health & wellness
Flat-Price PCOS Cycle Tracker
A flat-price symptom and cycle tracker aimed at people with PCOS and irregular cycles, intended to improve period prediction, surface patterns and export a doctor-ready report on…
In plain English
- What category is this?
- Clinics, coaches, and consumers buy for care, fitness, or wellbeing workflows. Here the focus is consumer health subscription.
- The idea, briefly
Build a flat-priced tracker built for PCOS/PMOS, endometriosis and PMDD that aims to predict irregular cycles from logged flow, BBT and medication, explain condition-specific symptom patterns, and export an unlimited doctor-ready report under the flat price. Note: whether general trackers fail PCOS users is inference from unopenable r/PCOS snippets, and Flo already supports irregular periods with a PCOS/endo Symptom Checker while Flochi advertises PCOS/endo personalization, so the differentiation is unproven.
More ▾- What buyers expect
People comparing tools like Flo, Clue, Flochi expect the basics to work without surprise fees or missing pieces. The loud complaints are: Basic tracking is paywalled and the app pushes hard for upgrades. A Flo reviewer writes the app 'prompts me to purchase the full subscription to be able to use even basic features that used to be available to everyone without purchase' and 'it literally forces you to agree and continue into the purchase by not allowing an exit button.' Scenario: a user logs a period, then is blocked from reading the insight about it; and clue's upsell is constant on the free tier. A reviewer notes 'It can be annoying how often you get pop-ups about going premium if you're using the free version.' Scenario: a free user is interrupted repeatedly while logging symptoms.
More ▾
- Sources
- 7
- Checked
- 5
- Competitors
- 3
- Gaps
- 7
- Page checked
- 5 · 71%
- Snippet only
- 2 · 29%
- Documented
- 7 · 58%
- Interpreted
- 5 · 42%
- pricing3
- complaint2
- revenue1
- market1
Competitors
3Parsed from public pricing blurbs (entry paid tier when available). Max in set: $9.99/mo.
| Competitor | From | Free tier | Source |
|---|---|---|---|
| Flo | See notes | — | apps.apple.com✓ |
| Clue | $9.99/mo | — | apps.apple.com✓ |
| Flochi | $5.99/mo | Yes | flochi.app✓ |
What customers complain about
7| Gap | Src |
|---|---|
Basic tracking is paywalled and the app pushes hard for upgrades. A Flo reviewer writes the app 'prompts me to purchase the full subscription to be able to use even basic features… | |
Clue's upsell is constant on the free tier. A reviewer notes 'It can be annoying how often you get pop-ups about going premium if you're using the free version.' Scenario: a free… | |
A search snippet attributed to an r/PCOS thread suggests general trackers do not model PCOS ('I don't know why trackers don't account for PCOS'). | |
A search snippet attributed to an r/PCOS thread suggests Clue is weak for irregularity and Flo is cluttered ('Clue was better but it's not really great for irregularity'; | |
Post-pregnancy and breastfeeding irregular cycles are treated as a long period and skew later predictions. A Clue reviewer writes 'my cycle was very irregular, | |
Condition-specific guidance and doctor-ready output sit behind premium. Flo's own feature table lists 'Personalized doctor's report' and 'Symptom Checker' as Premium-only. | |
Flochi's own comparison table marks Flo and Clue as lacking condition-aware personalization for PCOS, |
Documented Interpreted
How competitors find customers
3| Tactic | Src |
|---|---|
| Put up a landing page whose copy quotes the community's own complaint, gate early access behind an email waitlist, | flochi.app✓ |
| Pitch Apple an App Store 'Special Event' around a condition or life-stage keyword. documented: Flo currently runs one for perimenopause features. | apps.apple.com✓ |
| Seed the waitlist directly in the condition community where the complaint is already posted (r/PCOS) by replying with a link where users ask for a PCOS-aware tracker. | reddit.com· |
Your angle & pricing wedge
| Piece | Claim | Src |
|---|---|---|
| Angle | A flat-priced tracker built for PCOS/PMOS, endometriosis and PMDD that aims to predict irregular cycles from logged flow, BBT and medication, | |
| Wedge | Charge one flat annual price (about $19.99) that includes condition-aware tracking and unlimited doctor-ready reports, |
How others got traction
3| Move | Why | Src |
|---|---|---|
| Keep basic period tracking free and charge for insights and reports (Flo's freemium model). | Founder-attributed in Flo's own support reply: premium funds development while the basics stay free. | apps.apple.com✓ |
| Name the exact condition and ship early access through an Apple TestFlight waitlist (Flochi). | Founder-attributed on the landing page (a waitlist gates the TestFlight link); the acquisition effect is my inference from the page's compl… | flochi.app✓ |
| Publish a large, editorially reviewed health library to pull in search traffic (Clue's 400+ article… | Interpreted: the library acts as an SEO and education top-of-funnel that feeds app installs, not a claim the company makes about conversion. | apps.apple.com✓ |
Market heat
Flo's App Store listing says the app is used by over 500 million people and defines that figure in its own footnote as total downloads (July 2026); it holds 2M App Store ratings at 4.7 and ranks #2 in Health & Fitness top free.
More ▾Flo's Premium page reports 3.4 million Flo Premium members, but the page's reference is dated 'As of October 6, 2023', so the figure is stale and not current.
Clue holds 405K App Store ratings at 4.8 and is listed as an FDA-registered medical device (owner/operator number 10061492).
A new condition-aware entrant (Flochi) advertises PCOS/endo/BC personalization in a paid tier and is in TestFlight beta (its landing page gates access behind a waitlist), signalling active entry into PCOS/endo tracking. The paid tier is advertised but is not shown as purchasable.
More ▾
Revenue signals
3| Signal | Src |
|---|---|
Self-reported by Flo: 3.4 million Flo Premium members (the page reference is dated 'As of October 6, 2023', | flo.health✓ |
Comparable trackers price at $39.99-$59.99/yr (Clue Plus $39.99; Flo Premium $47.99-$59.99, | apps.apple.com✓ |
Health and fitness consumer apps churn hard: a Sahha review (itself citing secondary studies) reports a median 70% discontinuation within the first 100 days an… | sahha.ai✓ |
Should you build this?
People with PCOS and other irregular-cycle conditions might pay for a tracker that aims to predict their cycles and turns their data into something a doctor can use, but this is a hypothesis, not proven demand. People already pay at scale: Flo's listing claims 500M downloads and 2M ratings (downloads, July 2026), Flo reports 3.4M Premium members as of Oct 2023, and Flo's own feature table confirms the personalized doctor's report and Symptom Checker are Premium-only. The core opening, however, is unproven and partly contradicted by the opened sources: Flo's listing states it supports irregular periods and its Premium Symptom Checker covers PCOS/endometriosis/fibroids, and Flochi already advertises PCOS/endo/BC personalization in its paid tier. The only evidence that general trackers fail PCOS users is two r/PCOS search snippets that could not be opened, so it is inference, not observation; the cited Clue/Flo reviews speak to pop-up upsells and postpartum cycle skewing, not PCOS irregularity. Health apps churn badly and incumbents could add a condition mode, so do not assume this will work. Validation step: publish a one-page waitlist that quotes the r/PCOS complaint, show a $19.99/year flat price, run it for two weeks in PCOS communities plus one small Reddit ad test, and build only if at least 15% of visitors join the waitlist and 10 people pre-pay.
More ▾
All sources
7| Source | Kind | Status | Accessed |
|---|---|---|---|
| pricing | page checked | 2026-10-04 | |
| pricing | page checked | 2026-10-04 | |
| pricing | page checked | 2026-10-04 | |
| complaint | snippet only | 2026-10-04 | |
| complaint | snippet only | 2026-10-04 | |
| revenue | page checked | 2026-10-04 | |
| market | page checked | 2026-10-04 |